Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kyle

Showing results (81-90 of 167) with videos related to

Pageof 17
Sort By:
British Journal of Cancer|July 7, 2011
Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell linesA Peasland, L-Z Wang, E Rowling, et al.
Environmental Management|June 27, 2026
Adaptive Modeling to Inform Environmental ManagementKatie Irving, Rupert Mathwin, Christopher J Kotalik, et al.
Journal of Virology|June 21, 2013
Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protectionSoila Sukupolvi-Petty, James D Brien, S Kyle Austin, et al.
Open Forum Infectious Diseases|December 16, 2025
Infectious Diseases Telehealth Outcomes and Opportunities for Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Discharged From 18 Small Community HospitalsJohn J Veillette, Stephanie S May, Nick Tinker, et al.
Plos Pathogens|April 7, 2010
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1Bimmi Shrestha, James D Brien, Soila Sukupolvi-Petty, et al.
Journal of Virology|September 21, 2007
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopesSoila Sukupolvi-Petty, S Kyle Austin, Whitney E Purtha, et al.
Journal of Virology|July 2, 2010
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2Soila Sukupolvi-Petty, S Kyle Austin, Michael Engle, et al.
Plos Pathogens|April 19, 2014
Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagementMelissa A Edeling, S Kyle Austin, Bimmi Shrestha, et al.
Molecular Imaging and Biology|July 10, 2013
Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancersHyunki Kim, Christopher J Rigell, Guihua Zhai, et al.
Open Forum Infectious Diseases|November 16, 2022
A Fully Integrated Infectious Diseases and Antimicrobial Stewardship Telehealth Service Improves <i>Staphylococcus aureus</i> Bacteremia Bundle Adherence and Outcomes in 16 Small Community HospitalsJohn J Veillette, Stephanie S May, Alithea D Gabrellas, et al.
Pageof 17

Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
British Journal of Cancer|July 7, 2011
Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell linesA Peasland, L-Z Wang, E Rowling, et al.
Environmental Management|June 27, 2026
Adaptive Modeling to Inform Environmental ManagementKatie Irving, Rupert Mathwin, Christopher J Kotalik, et al.
Journal of Virology|June 21, 2013
Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protectionSoila Sukupolvi-Petty, James D Brien, S Kyle Austin, et al.
Open Forum Infectious Diseases|December 16, 2025
Infectious Diseases Telehealth Outcomes and Opportunities for Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Discharged From 18 Small Community HospitalsJohn J Veillette, Stephanie S May, Nick Tinker, et al.
Plos Pathogens|April 7, 2010
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1Bimmi Shrestha, James D Brien, Soila Sukupolvi-Petty, et al.
Journal of Virology|September 21, 2007
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopesSoila Sukupolvi-Petty, S Kyle Austin, Whitney E Purtha, et al.
Journal of Virology|July 2, 2010
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2Soila Sukupolvi-Petty, S Kyle Austin, Michael Engle, et al.
Plos Pathogens|April 19, 2014
Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagementMelissa A Edeling, S Kyle Austin, Bimmi Shrestha, et al.
Molecular Imaging and Biology|July 10, 2013
Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancersHyunki Kim, Christopher J Rigell, Guihua Zhai, et al.
Open Forum Infectious Diseases|November 16, 2022
A Fully Integrated Infectious Diseases and Antimicrobial Stewardship Telehealth Service Improves <i>Staphylococcus aureus</i> Bacteremia Bundle Adherence and Outcomes in 16 Small Community HospitalsJohn J Veillette, Stephanie S May, Alithea D Gabrellas, et al.
Pageof 17